Repurposing enzymes to degrade complex biofilms containing two bacteria and improve antibiotic activity
Comparing how effective and safe 14 days and 28 days of inhaled aztreonam were at getting rid of a Pseudomonas bacterial lung infection.
Molecular fingerprinting of Pseudomonas aeruginosa from PWCF, and a UK reference laboratory investigation into frequency of cross-infection
A step forward in the development of a safe anti-inflammatory molecule for the chronic respiratory disease of people with CF
Early acquisition and conversion of Pseudomonas aeruginosa in Hispanic youth with cystic fibrosis in the United States
